Aspira Pathlab Statements
54
Aspira Pathlab Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
72.796
14.427
58.369
—
32.575
70.845
-12.476
-1.733
1.764
-12.445
—
-12.445
-1.21
10.281
59.253
100
11.803
20.1
47.45
79.9
—
0
29.406
49.1
62.221
102.7
-14.771
-22.8
-1.944
-2.9
2.446
4.3
-14.269
-21.4
—
0
-14.269
-21.4
-1.391
10.261
77.811
100
12.715
16.9
65.096
83.1
—
0
29.191
41
63.182
90
1.914
-7
-1.991
-2.8
1.891
2.2
1.814
-7.6
—
0
1.814
-7.6
0.195
10.65
66.758
100
12.257
18.6
54.501
81.4
—
0
26.737
36.6
56.338
79.8
-1.837
1.5
-2.182
-2.9
1.318
1.8
-2.701
0.4
—
0
-2.701
0.4
-0.265
10.239
101.68
100
17.513
15
84.162
85
—
0
26.567
23.6
59.209
56.2
24.953
28.8
-2.332
-2.8
0.493
0.5
23.114
26.5
—
0
23.114
26.5
2.243
10.314
93.745
100
13.868
18.3
79.877
81.7
—
0
23.627
34.9
57.458
76.3
22.419
5.4
-1.394
-2
0.455
0.7
21.48
4.1
—
0
21.48
4.1
2.09
10.301
83.075
100
13.2
14.8
69.875
85.2
—
0
22.168
27.3
59.652
70.2
10.223
14.9
-4.086
-4.7
0.682
0.08
6.819
10.3
—
0
6.819
10.3
0.685
9.87
68.979
100
13.137
19.2
55.842
80.8
—
0
18.089
17.7
45.378
52.8
10.464
28
-4.829
-4.6
1.356
1.3
6.991
24.7
—
0
6.991
24.7
0.75
9.278
41.879
100
10.151
24.8
31.728
75.2
—
0
26.348
69.4
50.943
131.5
-19.216
-56.3
-5.229
-12.5
1.404
3.5
-23.041
-65.3
0.289
1.5
-23.33
-66.8
-3.149
7.839
42.286
100
9.725
19.2
32.561
80.8
—
0
23.129
51.7
48.226
110.6
-15.665
-29.8
-4.888
-10.4
1.477
3.2
-19.076
-37
—
0
-19.076
-37
-2.33
8.188